Trial intelligence / Profile preview

Intranasal Ketamine vs Midazolam and Fentanyl for Pediatric Laceration Repair

NCT03528512Phase 4Terminated

Sponsor
Corewell Health
Start
Sep 2018
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketamine in laceration, sponsored by Corewell Health. Started Sep 2018; status: terminated.

02

Drugs

ketamine
03

Conditions

laceration

Beyond the preview

Go deeper on NCT03528512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03528512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call